Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 49
Selected: 0
NCT IDTitle
NCT01536691Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone
NCT04761744A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers
NCT06083662Neratinib and Trastuzumab Biosimilar in Patients with HER2 Mutated Advanced Solid Cancers
NCT01352494Neoadjuvant Chemotherapy With Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
NCT03518502Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis
NCT05079503Gut Microbiome and Its Immune Modulation in Locally Advanced Rectal Cancer
NCT00818090Paclitaxel and Cisplatin for Thymic Neoplasm
NCT04753203Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients
NCT04077255EGFR-targeted Therapy for Gastric Cancer
NCT04751955A Phase lb/ll, Open Label, Single Arm Study With Olinvacimab and Capecitabine in mCRC Patients (OLCAP)
NCT03975179Omitting vs. Doing Intraoperative Frozen Section Biopsy for Margin Status in Breast Conserving Surgery
NCT00912938Evaluate the Relationship of Bone Remodeling Markers for Skeletal Complications in Metastatic Breast Cancer Patients
NCT03292250Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]
NCT03414814Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation
NCT00343668S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer
NCT00287768Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
NCT00595348Korean Hereditary Breast Cancer Study
NCT00912639A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer
NCT00912548Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women
NCT00527930Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer
NCT04116125Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) Trial
NCT05904457A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer
NCT04247633High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)
NCT01741116Dovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer
NCT04061863Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer
NCT00913016Assessment of Quality of Life, Bone Density and Safety in Postmenopausal Breast Cancer Patients With Letrozole Therapy
NCT01224652Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy
NCT03193788Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy
NCT00973037CYP2D6 Genotype on the Clinical Effect of Tamoxifen
NCT05525858KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II
NCT00561119Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer
NCT06446570Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma
NCT02273375Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC
NCT01196559Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer
NCT03296306Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma
NCT00819559Preoperative Chemoradiotheray for Rectal Cancer
NCT03423199PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY
NCT01593293Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer
NCT01069211Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women
NCT01622361Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer
NCT06237205Genome-Based Assessment of Niraparib (ZEJULA®) Efficacy in Advanced Solid TumorS With Homologous Recombination Deficiency
NCT01072318Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene
NCT02114359Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
NCT04202328T-DM1 in HER2-positive Metastatic/Relapsed Breast Cancer
NCT01351597A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer
NCT00830245A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer
NCT04938583Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
NCT03698383Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer
NCT01952951Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer